Australia
+919359902383
+919359902383

ELIQUIS Apixaban 2.5 mg Tablet Supplier in Sydney | @ErnestPharmaceutical

ELIQUIS – Apixaban 2.5 mg Tablet

Export-Grade Quality with Fast & Secure Delivery

Powered by Ernest Pharmaceutical Group

(All brands under Ernest Pharmaceutical Pvt. Ltd.)

@ERNESTVISION | ERNEST PHARMACEUTICAL PVT. LTD.

For global exports, OEM branding & distributor partnerships
πŸ“§ Emailexports@ernestpharmaceuticals.com

@ERNESTIMPEXPHARMACEUTICALPVTLTD

For bulk quotations, availability, and orders, please contact us:

πŸ“§ Email: exports@ernestpharmaceuticals.com

🌐 www.ernestpharmaceuticals.com | www.ernestimpex.com

Amit Rai: WhatsApp link https://wa.me/message/M6GESWXSIOZMD1

πŸ“² WhatsApp: β€ͺβ€ͺβ€ͺ+91 94054 76170


Product Description

ELIQUIS Tablet contains Apixaban 2.5 mg, an oral anticoagulant belonging to the class of direct factor Xa inhibitors. It is used in physician-supervised medical settings to help reduce the risk of blood clot formation in patients requiring anticoagulation therapy at a lower dose strength.

Apixaban selectively inhibits factor Xa, an essential component of the coagulation cascade, thereby reducing thrombin generation and clot development. The 2.5 mg strength is commonly prescribed for dose-adjusted therapy, including elderly patients or those with specific clinical considerations.

ELIQUIS 2.5 mg tablets are formulated to provide accurate dosing, predictable bioavailability, and consistent quality, making them suitable for regulated pharmaceutical distribution, wholesale trade, and export supply.



Composition

  • Active Ingredient: Apixaban

  • Strength: 2.5 mg

  • Dosage Form: Tablet


Mechanism of Action

Apixaban works by selectively and reversibly inhibiting factor Xa, preventing the conversion of prothrombin into thrombin. This action reduces fibrin clot formation without directly affecting platelet aggregation.



Indications/Uses

  • Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (as prescribed)

  • Prevention of venous thromboembolism following orthopedic surgery

  • Dose-adjusted anticoagulant therapy in selected patients

  • Prevention of recurrent blood clots (as directed by a physician)



Key Features

βœ” Direct oral anticoagulant (DOAC)
βœ” Lower-dose 2.5 mg strength for tailored therapy
βœ” Predictable anticoagulant effect
βœ” No routine coagulation monitoring required (as prescribed)
βœ” Suitable for Distributor, Wholesale Supplier & Bulk Supplier channels



Dosage & Administration

Dosage and duration should be individualized by a qualified healthcare professional, considering patient age, renal function, body weight, and clinical condition.



Storage Instructions

  • Store in a cool, dry place

  • Protect from moisture and direct sunlight

  • Keep out of reach of children


Packaging

  • Blister/strip packing

  • Bulk packaging available for institutional and export supply


Documentation Details (Available on Request)

  • Certificate of Analysis (COA)

  • Material Safety Data Sheet (MSDS)

  • Batch Manufacturing Record (BMR)

  • Batch Release Certificate

  • Product Specification Sheet

  • Certificate of Origin (COO)

  • Commercial Invoice & Packing List

ELIQUIS Apixaban 2.5 mg Tablets are low-dose oral anticoagulants used to reduce the risk of blood clots, stroke, and embolism. Available for bulk and wholesale supply.

Why Choose Ernest Pharmaceutical Pvt. Ltd.?

πŸ’  ISO-Certified Global Exporter
πŸ’  10+ Years of International Healthcare Export Experience
πŸ’  Private Label & OEM Supply Options
πŸ’  Complete Regulatory Documentation (COA, COPP, COO, MSDS, etc.)
πŸ’  Temperature-Controlled International Logistics via DHL, FedEx & Aramex



Payment & Logistics

πŸ’± Accepted Payment Modes

  • TT (Telegraphic Transfer)

  • International Bank Transfer

🚚 Fast Dispatch & Worldwide Delivery Available



Contact for Bulk Orders & Latest Price

Ernest Pharmaceutical Pvt. Ltd.
πŸ“§ Emailexports@ernestpharmaceuticals.com

 2025-12-31T06:22:57

Keywords